Product evidence summary
Ingredient and Evidence Breakdown for Dulkin Mushroom Coffee
Summary
Dulkin Mushroom Coffee is real Arabica coffee combined with a ten-mushroom extract blend. Its most concrete, fully verifiable feature is caffeine: at 48 mg per serving it delivers roughly half the caffeine of a standard cup of brewed coffee, which is the plainest explanation for customers describing it as gentler on the stomach and steadier across the afternoon. The mushroom side is supported by a body of human and laboratory research that varies in strength by species: the evidence is most developed for Cordyceps (exercise capacity and energy) and Lion's Mane (attention and mood), is emerging but of lower certainty for Reishi (calm and sleep), and is mostly early-stage for the immune- and gut-oriented species. Research on one mushroom extract does not automatically transfer to the finished coffee, because dose, extraction and preparation differ, so the language throughout is deliberately 'studied for' and 'may support,' not 'proven to treat.'
1.The product at a glance
| Attribute | Value |
|---|---|
| Serving size | 1 scoop (3.5 g) |
| Servings per container | 30 |
| Caffeine per serving | 48 mg (about half a standard cup) |
| Mushroom extracts | 10 species × 200 mg = 2,000 mg total |
| Base | Arabica coffee; contains coconut milk powder |
The ten mushroom extracts are lion's mane, cordyceps, chaga, reishi, turkey tail, shiitake, maitake, king trumpet, agaricus blazei and willow bracket, each at 200 mg. Values are from the product's supplement facts panel.
2.Caffeine: about half a cup, by design
A standard 8 oz cup of brewed coffee contains roughly 95–165 mg of caffeine, and specialty brewing methods can run higher. Dulkin's 48 mg per serving is close to half that. The U.S. Food and Drug Administration considers up to 400 mg per day generally safe for healthy adults; a lower per-serving dose leaves more headroom and a gentler curve, which is the most defensible basis for a 'steadier, easier-on-me' positioning. This matters because an estimated 10–15% of people are slow caffeine metabolisers (a common CYP1A2 variant) and can feel jittery or unsettled on a dose others clear easily. Framing Dulkin around less caffeine, rather than a specific health outcome, is both accurate and distinctive. [1][2]
3.The ten mushrooms and what they are studied for
The table below summarises what each extract is traditionally used or studied for and how strong the human evidence currently is. 'Emerging' means small or mixed human trials; 'Early' means mostly laboratory or animal work with limited human data. None of these are disease claims.
| Mushroom | Studied / traditional use | Human evidence |
|---|---|---|
| Lion's Mane (Hericium erinaceus) | Attention, memory, mood | Emerging, mixed [3] |
| Cordyceps (C. militaris) | Exercise capacity, energy, stamina | Emerging, promising [4][5] |
| Reishi (Ganoderma lucidum) | Calm, sleep, fatigue | Limited, low certainty [6] |
| Turkey Tail (Trametes versicolor) | Gut / prebiotic, immune (PSP) | Human gut trial [7] |
| Chaga (Inonotus obliquus) | Antioxidant, immune | Early; safety caveat [8] |
| Shiitake (Lentinula edodes) | Immune support (beta-glucans) | Small human trial [9] |
| Maitake (Grifola frondosa) | Immune support (beta-glucans) | Early [10] |
| King Trumpet (Pleurotus eryngii) | Beta-glucans, lipid / metabolic | Early [11] |
| Agaricus blazei (A. blazei Murill) | Immune modulation | Early; human safety data [12] |
| Willow Bracket (Phellinus igniarius) | Traditional antioxidant / immune | Traditional; limited data |
'Emerging' means small or mixed human trials; 'Early' means mostly laboratory or animal work with limited human data. None of these are disease claims.
Energy and focus
This is the blend's best-supported story. In a randomised, double-blind crossover trial, a standardised Cordyceps militaris extract taken before exercise produced faster reaction times versus placebo, and three weeks of supplementation improved VO2max (a measure of aerobic capacity) more than placebo; the effect tends to be clearest in non-athletes, who have more room to improve. [4][5] Lion's Mane has several human trials for attention, working memory, morning restedness and mood; results are mixed and benefits generally build over weeks rather than from a single cup, so it is honestly described as a supporting ingredient, not a switch. [3]
Calm and sleep
Reishi has a long traditional use as a calming agent, and a recent randomised comparison reported a larger reduction in insomnia-severity score than melatonin. However, a GRADE-assessed systematic review rated the overall certainty of Reishi evidence as low, so the appropriate wording is 'may support relaxation and sleep quality,' never a treatment claim for insomnia. [6]
Gut and immune
Turkey Tail is the most directly relevant to the 'easier on my stomach' theme: its polysaccharopeptide (PSP) acted as a prebiotic in an eight-week human study, shifting gut bacteria toward Bifidobacterium and Lactobacillus. [7] The remaining species — Shiitake, Maitake, King Trumpet, Agaricus blazei and Chaga — are rich in beta-glucans and show immune-modulating activity, but the human evidence is earlier and mostly at the ingredient rather than finished-product level. [8][9][10][11][12] Combined with the lower caffeine, the gut-comfort angle is plausible and can be stated as such, without promising relief from any digestive condition.
4.Independent clinical context (a different product, not Dulkin)
The strongest human trial in this category tested Restake, a five-mushroom supplement — not Dulkin — in a 12-week randomised, double-blind, placebo-controlled study of 50 adults with moderate to severe stress. It is useful as category evidence that a defined multi-mushroom supplement can move validated wellness measures. The figures below are mean changes in questionnaire scores, not the percentage of people who felt better, and they belong to the tested product, not to Dulkin. [13]
| Outcome | Mushroom blend | Placebo | Between groups |
|---|---|---|---|
| Perceived-stress score | 17.8% lower | 10.1% lower | Significant |
| Physical-fatigue score | 9.2% lower | 2.1% lower | Significant |
| Sleep-quality score | 11.1% better | 1.0% better | Significant |
| State-anxiety score | 8.7% lower | 4.9% lower | Significant |
Mean score changes from baseline after 12 weeks for the tested Restake formulation (50 adults). These are not Dulkin results and not percentages of participants reporting improvement. Dulkin shares the multi-mushroom category but differs in blend, dose, extraction and caffeine, and was not the product studied.
5.By the numbers (all sourced)
- 48 mg — caffeine, about half a standard cup [1]
- 2,000 mg — mushroom extracts per serving
- 10 — mushroom species in the blend
- 12 weeks — independent study on a related blend, not Dulkin [13]
These replace the earlier customer-survey rings. Each is a fact about the product or a figure from a named study, so nothing here depends on data we no longer hold.
6.Safety and who should be cautious
These are genuine cautions, not boilerplate. Chaga is high in oxalates and has been linked to kidney injury at high intake, so it is not appropriate for people with kidney stones, reduced kidney function, or conditions that raise oxalate absorption (such as inflammatory bowel disease). [8] Reishi may interact with anticoagulant / blood-thinning medication. There is still real caffeine in the product, so it is not caffeine-free, and sensitive or slow-metaboliser individuals should account for it. The product contains coconut milk powder, which rules it out for people with a coconut or tree-nut allergy. Anyone who is pregnant or breastfeeding, has kidney stones or kidney disease, or takes blood thinners, diabetes or blood-pressure medication should ask a pharmacist first. Dulkin is a food, not a medicine.
7.References
- U.S. Food and Drug Administration. Spilling the Beans: How Much Caffeine is Too Much? Consumer guidance. Accessed September 2026.
- General consumer references on the caffeine content of brewed coffee (approx. 95–165 mg per 8 oz cup) and the CYP1A2 slow-metaboliser variant (approx. 10–15% of people). Accessed September 2026.
- Acute effects of a standardised extract of Hericium erinaceus (Lion's Mane) on cognition and mood in healthy younger adults: a double-blind randomised placebo-controlled study. Frontiers in Nutrition. 2025. doi:10.3389/fnut.2025.1405796.
- Acute Cordyceps militaris supplementation and elevated resting oxygen uptake with faster reaction times: a randomised crossover trial. PLOS One. 2025. doi:10.1371/journal.pone.0351725.
- Current evidence of ergogenic and post-exercise recovery effects of dietary supplementation with Cordyceps militaris in humans: a narrative review. Nutrients (MDPI). 2026;18(5):781.
- The nutritional significance of Ganoderma lucidum (Reishi) on human health: a GRADE-assessed systematic review and meta-analysis of clinical trials. 2025. PMC12160064.
- Pallav K, Dowd SE, Villafuerte J, et al. Effects of polysaccharopeptide from Trametes versicolor and amoxicillin on the gut microbiome of healthy volunteers: a randomised clinical trial. Gut Microbes. 2014;5(4):458–467. doi:10.4161/gmic.29558.
- Chaga mushroom-induced oxalate nephropathy that clinically manifested as nephrotic syndrome: a case report. 2022. PubMed PMID 35451393.
- Dai X, Stanilka JM, Rowe CA, et al. Consuming Lentinula edodes (Shiitake) mushrooms daily improves human immunity: a randomised dietary intervention in healthy young adults. J Am Coll Nutr. 2015;34(6):478–487.
- Vetvicka V, Vetvickova J. Immune-enhancing effects of Maitake (Grifola frondosa) and Shiitake (Lentinula edodes) extracts (laboratory / in-vitro study). Ann Transl Med. 2014. PubMed PMID 25332990.
- The performance of Pleurotus eryngii (King Trumpet) beta-glucans on protein digestion and free amino acids in obese adults: a randomised crossover study. Foods (MDPI). 2025;14(15):2649. doi:10.3390/foods14152649.
- Immunomodulatory effects of Agaricus blazei Murill: human safety data and early clinical evidence. Biomedicines (MDPI). 2026;14(1):53; and review, PMC3168293.
- Hisamuddin ASD, et al. Adaptogenic effects of mushroom blend supplementation on stress, fatigue, and sleep: a randomised, double-blind, placebo-controlled trial (the Restake study). Brain and Behavior. 2026;16:e71193. doi:10.1002/brb3.71193.